Life Science Data Needs an Upgrade: Veeva Has Answers
Veeva’s Anthony Billinger breaks down how outdated commercial data models are costing biopharma big—and how Veeva Compass is changing the game.
Veeva’s Anthony Billinger breaks down how outdated commercial data models are costing biopharma big—and how Veeva Compass is changing the game.
